EDGAR Filing Documents for 0001209191-09-049180

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001209191-09-049180

Filing Date

2009-10-19

Accepted

2009-10-19 20:44:54

Documents

Period of Report

2009-10-15

Document Format Files

Seq	Description	Document	Type	Size
1	MAIN DOCUMENT DESCRIPTION	c91247_4x0.html	4
1	MAIN DOCUMENT DESCRIPTION	c91247_4x0.xml	4	5959
	Complete submission text file	0001209191-09-049180.txt		8022

Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100

Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488

Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT ST, SCIENCE PARK, POB 455 CARMIEL L3 20100

Business Address

Type: 4 | Act: 34 | File No.: 001-33357 | Film No.: 091126853